VF
TVRD

Virtu Financial’s Tvardi Therapeutics TVRD Stock Holding History

Virtu Financial’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,614
Closed -$18K – 2210
2024
Q3 		$18K Sell
1,614
-497
-24% -$5.83K ﹤0.01% 1140
2024
Q2 		$20K Buy
+2,111
New +$50.4K ﹤0.01% 1035
2023
Q2 		– Sell
-572
Closed -$101K – 2158
2023
Q1 		$101K Buy
+572
New +$192K 0.01% 983
2020
Q4 		– Sell
-371
Closed -$170K – 1866
2020
Q3 		$170K Buy
+371
New +$216K 0.03% 623
2019
Q1 		– Sell
-537
Closed -$251K – 1937
2018
Q4 		$251K Buy
537
+236
+78% +$152K 0.01% 813
2018
Q3 		$259K Buy
+301
New +$217K 0.02% 931
2018
Q2 		– Sell
-314
Closed -$140K – 2587
2018
Q1 		$140K Buy
+314
New +$152K 0.01% 1486
2017
Q4 		– Sell
-483
Closed -$238K – 3122
2017
Q3 		$238K Buy
+483
New +$242K 0.01% 1637

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's TVRD Position: Q4 2024 in Review

Virtu Financial sold out of Tvardi Therapeutics (TVRD) in Q4 2024, closing a stake of 1,614 shares — an estimated $18K sold.

Virtu Financial first reported a position in TVRD in Q3 2017 and held it in 8 quarters. The position peaked at $259K in Q3 2018. 43 funds tracked by Wall St. Rank hold TVRD as of Q4 2024.

  • Virtu Financial reported no remaining Tvardi Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 1,614 Tvardi Therapeutics shares in Q4 2024, an estimated $18K.
  • Virtu Financial first reported a position in Tvardi Therapeutics in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's Tvardi Therapeutics position peaked at $259K in Q3 2018.
  • 43 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.